New research reveals that tirzepatide and semaglutide both offer strong, early heart-protective effects. A major new ...

Lundbeck's new drug application (NDA) for Vyepti® (eptinezumab) accepted by Japan's Ministry of Health, Labor and Welfare (MHLW), marking a significant ...

Diabetes is rising at an alarming rate among young adults in India, driven by genetic predisposition, unhealthy lifestyles, ...